Eurofins Scient (OTCMKTS:ERFSF) Sees Large Increase in Short Interest

Eurofins Scient (OTCMKTS:ERFSF) was the recipient of a significant growth in short interest in February. As of February 13th, there was short interest totaling 304,127 shares, a growth of 114.4% from the January 29th total of 141,869 shares. Approximately 0.2% of the company’s stock are short sold. Based on an average daily volume of 9,553 shares, the short-interest ratio is presently 31.8 days. Based on an average daily volume of 9,553 shares, the short-interest ratio is presently 31.8 days. Approximately 0.2% of the company’s stock are short sold.

Eurofins Scient Stock Up 2.1%

OTCMKTS ERFSF traded up $1.70 on Friday, hitting $81.76. 1,580 shares of the stock were exchanged, compared to its average volume of 4,486. Eurofins Scient has a fifty-two week low of $48.55 and a fifty-two week high of $86.20. The company has a 50-day moving average price of $79.77 and a 200-day moving average price of $75.01. The company has a current ratio of 1.26, a quick ratio of 1.19 and a debt-to-equity ratio of 0.77.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the stock. Citigroup reissued a “neutral” rating on shares of Eurofins Scient in a research report on Monday, February 2nd. BNP Paribas Exane upgraded Eurofins Scient to an “outperform” rating in a research note on Monday, January 5th. One research analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold”.

Eurofins Scient Company Profile

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.